Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-25-000216
Filing Date
2025-08-05
Accepted
2025-08-05 16:02:33
Documents
87
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20250630.htm   iXBRL 10-Q 1517515
2 EX-31.1 a2025q210-qexhibit311.htm EX-31.1 10578
3 EX-31.2 a2025q210-qexhibit312.htm EX-31.2 10592
4 EX-32.1 a2025q210-qexhibit321.htm EX-32.1 6253
10 GRAPHIC vrtx-20250630_g1.jpg GRAPHIC 38127
  Complete submission text file 0000875320-25-000216.txt   8896494

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20250630.xsd EX-101.SCH 52122
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20250630_cal.xml EX-101.CAL 103908
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20250630_def.xml EX-101.DEF 312774
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20250630_lab.xml EX-101.LAB 667301
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20250630_pre.xml EX-101.PRE 512092
90 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20250630_htm.xml XML 1532486
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 251184771
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)